The U.S. new cases 7-day rolling average are 4.8 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 15.2 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 54,434
U.S. Coronavirus deaths are at 1,245
U.S. Coronavirus immunizations have been administered to 33.1 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases worsened and deaths improved
What we know about India s Covid-19 vaccine
AstraZeneca Vax Flops Against South African Variant in Early Trial
Some long-haul covid-19 patients say their symptoms are subsiding after getting vaccines
email article
AstraZeneca s COVID-19 vaccine was not protective against mild-to-moderate disease from either the so-called South African variant (B.1.351) or the wild type virus, an interim analysis of phase Ib/II data found.
Overall vaccine efficacy against mild-to-moderate COVID-19 in South Africa was 21.9% (95% CI -49.9 to 59.8), and efficacy against B.1.351 was 10.4% (95% CI -76.8 to 54.8), reported Shabir Madhi, PhD, of University of the Witwatersrand in Gauteng, South Africa, and colleagues, in the
Previously, pooled efficacy data on the AstraZeneca vaccine from the U.K., Brazil, and South Africa, prior to B.1.351 s emergence, showed overall efficacy of 66.7% (95.8% CI 57.4-74.0), as well as 74.6% efficacy against the so-called U.K. variant, B.1.1.7.